Allworth Financial LP Amphastar Pharmaceuticals, Inc. Transaction History
Allworth Financial LP
- $15.5 Billion
- Q2 2024
A detailed history of Allworth Financial LP transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Allworth Financial LP holds 1,426 shares of AMPH stock, worth $68,476. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,426
Previous 1,426
-0.0%
Holding current value
$68,476
Previous $62,000
8.06%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding AMPH
# of Institutions
279Shares Held
34.2MCall Options Held
25.5KPut Options Held
24.8K-
Black Rock Inc. New York, NY5.94MShares$285 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$128 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.94MShares$93.4 Million0.19% of portfolio
-
Td Asset Management Inc1.69MShares$81.2 Million0.07% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$77.9 Million0.05% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $2.35B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...